Target- |
Mechanism- |
|
Originator Org.- |
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
Originator Org.- |
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
人工熊胆粉替代熊胆粉的熊胆胶囊治疗急性咽炎肝胃郁热证区组随机、双盲、多中心等效性临床研究
[Translation] A randomized, double-blind, multicenter clinical trial on the equivalence of bear bile capsules with artificial bear bile powder instead of bear bile powder in the treatment of acute pharyngitis with liver and stomach stagnation and heat syndrome
探索性试验:初步对比人工熊胆粉替代熊胆粉的熊胆胶囊治疗急性咽
炎(肝胃郁热证)的有效性、安全性、合适剂量,为确证性试验设计
提供参考。
[Translation] Exploratory trial: Preliminary comparison of the effectiveness, safety, and appropriate dosage of bear bile capsules with artificial bear bile powder instead of bear bile powder in the treatment of acute pharyngitis (liver and stomach stagnation and heat syndrome), providing a reference for the design of confirmatory trials.
人工熊胆粉替代熊胆粉的熊胆胶囊治疗急性结膜炎(肝经火热证)区组随机、双盲、多中心等效性临床研究
[Translation] A randomized, double-blind, multicenter clinical study on the equivalence of bear bile capsules with artificial bear bile powder instead of bear bile powder in the treatment of acute conjunctivitis (liver meridian fire and heat syndrome)
初步对比人工熊胆粉替代熊胆粉的熊胆胶囊治疗急性结膜炎(肝经火热证)有效性、安全性、合适剂量,为确证性试验设计提供参考。
[Translation] A preliminary comparison was made on the effectiveness, safety and appropriate dosage of bear bile capsules containing artificial bear bile powder instead of bear bile powder in the treatment of acute conjunctivitis (liver meridian heat syndrome), providing a reference for the design of confirmatory trials.
[Translation] Phase I clinical human tolerance trial of artificial bear bile powder
以中国健康成年受试者为研究对象,进行人工熊胆粉临床人体耐受性研究,从安全的初始剂量开始,观察人体对该药的耐受性及其产生的不良反应,确定安全耐受的人用剂量,了解在此剂量下的不良反应,为人工熊胆粉的临床应用的安全性提供数据支持。
[Translation] Using healthy Chinese adult subjects as research subjects, a clinical human tolerance study of artificial bear bile powder was conducted. Starting from a safe initial dose, the tolerance of the human body to the drug and the adverse reactions it produced were observed, the safe and tolerable human dose was determined, the adverse reactions at this dose were understood, and data support was provided for the safety of the clinical application of artificial bear bile powder.
100 Clinical Results associated with Zhongshan Anshi Biopharmaceutical Co., Ltd.
0 Patents (Medical) associated with Zhongshan Anshi Biopharmaceutical Co., Ltd.
100 Deals associated with Zhongshan Anshi Biopharmaceutical Co., Ltd.
100 Translational Medicine associated with Zhongshan Anshi Biopharmaceutical Co., Ltd.